These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26349583)

  • 21. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
    Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG
    Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic profiles of clot-targeted plasminogen activators. Parameters determining potency and initial and maximal rates.
    Holvoet P; Dewerchin M; Stassen JM; Lijnen HR; Tollenaere T; Gaffney PJ; Collen D
    Circulation; 1993 Mar; 87(3):1007-16. PubMed ID: 8443877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced clot dissolution in vitro by 1.8-MHz pulsed ultrasound.
    Eggers J; Ossadnik S; Seidel G
    Ultrasound Med Biol; 2009 Mar; 35(3):523-6. PubMed ID: 19041172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of histotripsy combined with rt-PA in vitro.
    Bader KB; Haworth KJ; Shekhar H; Maxwell AD; Peng T; McPherson DD; Holland CK
    Phys Med Biol; 2016 Jul; 61(14):5253-74. PubMed ID: 27353199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolytic Capacity of Desmoteplase Compared to Tissue Plasminogen Activator in Rabbit Eyes.
    Voelter K; Tappeiner C; Klein K; Borel N; Bruetsch D; Laguna Sanz F; Pot SA
    J Ocul Pharmacol Ther; 2019; 35(1):66-75. PubMed ID: 30376399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cavitational mechanisms in ultrasound-accelerated fibrinolysis.
    Prokop AF; Soltani A; Roy RA
    Ultrasound Med Biol; 2007 Jun; 33(6):924-33. PubMed ID: 17434661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA.
    Frühwald T; Gärtner U; Stöckmann N; Marxsen JH; Gramsch C; Roessler FC
    BMC Neurol; 2019 Aug; 19(1):181. PubMed ID: 31375069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model.
    Sutton JT; Ivancevich NM; Perrin SR; Vela DC; Holland CK
    Ultrasound Med Biol; 2013 May; 39(5):813-24. PubMed ID: 23453629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis.
    Shaw GJ; Meunier JM; Lindsell CJ; Holland CK
    Ultrasound Med Biol; 2008 Nov; 34(11):1783-92. PubMed ID: 18468773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI-guided sonothrombolysis of rabbit carotid artery.
    Damianou C; Hadjisavvas V; Mylonas N; Couppis A; Ioannides K
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e113-21. PubMed ID: 24126288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull.
    Behrens S; Daffertshofer M; Spiegel D; Hennerici M
    Ultrasound Med Biol; 1999 Feb; 25(2):269-73. PubMed ID: 10320316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duty cycle dependence of ultrasound enhanced thrombolysis in a human clot model.
    Meunier JM; Holland CK; Lindsell CJ; Shaw GJ
    Ultrasound Med Biol; 2007 Apr; 33(4):576-83. PubMed ID: 17337113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of mild hypothermia on the thrombolytic efficacy of 120 kHz ultrasound enhanced thrombolysis in an in-vitro human clot model.
    Shaw GJ; Bavani N; Dhamija A; Lindsell CJ
    Thromb Res; 2006; 117(5):603-8. PubMed ID: 15951005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA; Huang TC; Keyt BA; Alevriadou BR
    Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots.
    Francis CW; Blinc A; Lee S; Cox C
    Ultrasound Med Biol; 1995; 21(3):419-24. PubMed ID: 7645133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.